Trials / Suspended
SuspendedNCT02594748
The Effects of Self-management Education Based on Theory of Planned Behavior on Patients With Type 2 Diabetes
The Effects of Self-management Education Based on Theory of Planned Behavior on Self-management and Quality of Life of Patients With Type 2 Diabetes and the Other Influencing Factors of Quality of Life
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 280 (estimated)
- Sponsor
- University of Turku · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The aims of the study are as follows: * To improve self-management intention and behavior of patients with type 2 diabetes (T2 DM). * To promote patients to make plans for their self-management and gradually integrate the self-management plan into their daily life. * To improve resilience, well-being, fatigue and quality of life of patients with T2 DM In order to achieve the aims, we have set the following objectives: * To develop and apply self-management education program based on the extended theory of planned behavior. * To evaluate the efficacy of the educational program: 1. Self-management education program delivered face to face (intervention group); (b) standard usual care (comparison group).
Detailed description
This study employs a quasi-experimental study design with an intervention and comparison group and follow-up of 3 months; there will be two measuring points (baseline and 3 months after the intervention) , and 9 measures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Self-management education | The intervention group will receive diabetes self-management education based on the idea of extended theory of planned behavior . |
| BEHAVIORAL | Routine care | They will attend the routine lecture in hospital sit and listen, usually 1-2 times during one week in hospital |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2017-06-01
- Completion
- 2019-12-01
- First posted
- 2015-11-03
- Last updated
- 2016-10-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02594748. Inclusion in this directory is not an endorsement.